windows 2000 online training
windows 2000 online training with http://www.mdnewscast.net

windows 2000 online training

Medical Newscast

News for 19-Jan-25

Source: MedicineNet Diabetes General
Health Tip: Prepare for Travel With Diabetes

Source: MedicineNet Diabetes General
Can Protein, Probiotics Help With Blood Sugar Control?

Source: MedicineNet Diabetes General
Jardiance (empagliflozin)

Source: MedicineNet High Blood Pressure General
Sharp Drop in Blood Pressure After Rx May Be Risky for Some Heart Patients

Source: MedicineNet High Blood Pressure General
Normal Blood Pressure in Clinic May Mask Hypertension

Source: MedicineNet High Blood Pressure General
Omega-3s a Recipe for Healthy Blood Pressure in Young Adults

Source: MedicineNet High Blood Pressure General
High Blood Pressure Rates Have Doubled Worldwide Since 1975

Source: MedicineNet Diabetes General
FDA OKs High-Tech Diabetes Device to Help Replace Fingerstick Tests

Source: MedicineNet Diabetes General
Daily Can of Soda Boosts Odds for Prediabetes, Study Finds

Source: MedicineNet High Blood Pressure General
Yoga Called Good Medicine for High Blood Pressure

Search the Web
windows 2000 online training
online flight training
online web training
microsoft access online training
online paralegal training
online training uk
online visual basic training
safety training online
delphi online training
online training log

The Best windows 2000 online training website

All the windows 2000 online training information you need to know about is right here. Presented and researched by http://www.mdnewscast.net. We've searched the information super highway far and wide to provide you with the best windows 2000 online training site on the internet today. The links below will assist you in your efforts to find the information that you are looking for about
windows 2000 online training.

windows 2000 online training

Medical Newscast
For information about Medical Newscasts look no further. We have links to great resources regarding all forms of medical internet broadcasting.
Medical Newscast

Many windows 2000 online training websites invite you to sign a Guestbook. They are not just doing this to get warm fuzzy feelings. windows 2000 online training retailers who are seriously committed to quality customer service want feedback. The best sort of windows 2000 online training feedback comes from windows 2000 online training shoppers. Makes sense doesn't it?

When you take the time to sign a windows 2000 online training Guestbook you are adding value to the relationship you have with the windows 2000 online training retailer. You may be able to offer valuable suggestions which will improve the windows 2000 online training shopping experience for other customers.

windows 2000 online training

Medical Newscast
For information about Medical Newscasts look no further. We have links to great resources regarding all forms of medical internet broadcasting.
Medical Newscast

If you're still reading and haven't visited the windows 2000 online training links yet, let me reveal how this web site happened. I was finding it extremely difficult getting the exact info I was looking for, I know some sites do have it, like the windows 2000 online training sites I listed above, but mostly web sites don't offer to the exact thing.

Instead of searching the web and going from one windows 2000 online training website to the next I thought I'd create my own windows 2000 online training site, and it's obvious I've only just made a start on it. Right now I haven't really got the content I want compiled, which is why I've listed these other, more established windows 2000 online training sites. One day soon this will be the best place to visit to find information or buy. Until then you'll have to be satisfied with the windows 2000 online training listings.

a Cold; Starve a Tumor

 by: ARA Content

(ARA) - One of the most exciting developments in modern medicine has been the discovery that cancerous tumors have the potential of being "starved" out of existence, or at least into dormancy. Scientists, doctors and, of course, patients, are all anticipating the prospect that cancer patients may take a drug that will stop a tumor in its track by cutting off the blood supply that nourishes it.

At the core of this medical breakthrough was the discovery that every tumor needs to "recruit" its own blood supply to flourish and grow. Scientists also found out that tumors actively "participated" in this process by secreting certain growth chemicals that would attract blood vessels to the tumor. Having identified this process, the next step was to determine if drugs could be created that could somehow arrest or reverse the progress of blood vessels amassing around a tumor.

The result has been a highly dynamic and exciting area of medicine called anti-angiogenesis (meaning "against the formation of new blood vessels") that focuses on inhibiting the growth of cancer by developing drugs that will prevent tumors from growing in size.

Currently, there are several drug companies that are on the cusp of introducing drugs that will work by the process of anti-angiogenesis. Generally speaking, the drugs seek to improve survival rates of cancer patients, as well as increase the length of time that patients survive. And unlike conventional cancer therapies that have punishing side effects, the new drugs seem to demonstrate few or no side effects for most people. Furthermore, some of the studies show that by utilizing both conventional treatments like radiation and/or chemotherapy in conjunction with anti-angiogenesis drugs, the cumulative effect is even more powerful.

One highly regarded company that is at the forefront of developing anti-angiogenesis drugs is Aeterna Laboratories, based in Quebec, Canada and traded on the Nasdaq market under the ticker symbol, AELA. The company's premier product, Neovastat, is currently being tested in clinical trials for a variety of cancers including lung, renal (kidney) and multiple myeloma (bone marrow). The results for the renal and multiple myeloma tests are scheduled to wrap up by the end of 2002 and, if conclusive, will be submitted to the Federal Drug Administration for review.

Out of all the drugs under development, Neovastat is unique because of its multi-functionality, which is its ability to shut down two pathways recognized as being responsible for promoting angiogenesis (in contrast to other drugs which just block one pathway). In clinical trials, Neovastat has been shown to have no side effects in most people. This is obviously a big advantage for people who know the agony of nausea, exhaustion and/or hair loss that can accompany chemotherapy drugs. In tests, Neovastat has been given to people in liquid oral form, generally the preferable form of drug delivery for patients.

If you are a cancer patient interested in clinical trial participation, you can get information about current trials by calling (888)-349-3232 If you are an oncologist, please contact Claude Hariton, Ph.D., vice president of Clinical and Regulatory Affairs at (418) 652-8525 ext. 306. To learn more about anti-angiogenesis drugs and Aeterna Laboratories, visit the Aeterna Web site at www.aeterna.com.

About The Author

Courtesy ARA Content, www.ARAcontent.com; e-mail: info@ARAcontent.com

Google

http://www.medmeet.com/
Take It Right | Medical Meetings On The Net | Medical Presentations | Medical Presentations | Medical Newscast

Present On The Net   MD Newscast   Take It Correctly